Directed Concentrating of Micro-/Nanoparticles via Near-Infrared Laser Generated Plasmonic Microbubbles

Generating Stable Nitrogen Bubble Layers on Poly(methyl methacrylate) Films by Photolysis of 2-Azidoanthracene

2-Azidoanthracene (2N3-AN) can act as a photochemical source of N2 gas when dissolved in an optically transparent polymer such as poly(methyl methacrylate) (PMMA). Irradiation at 365 or 405 nm of a 150 μm-thick polymer film submerged in water causes the rapid appearance of a surface layer of bubbles. The rapid appearance of surface bubbles cannot be explained by normal diffusion of N2 through the polymer and likely results from internal gas pressure buildup during the reaction. For an azide concentration of 0.1 M and a light intensity of 140 mW/cm2, the yield of gas bubbles is calculated to be approximately 40%. The dynamics of bubble growth depend on the surface morphology, light intensity, and 2N3-AN concentration. A combination of nanoscale surface roughness, high azide concentration, and high light intensity is required to attain the threshold N2 gas density necessary for rapid, high-yield bubble formation. The N2 bubbles adhered to the PMMA surface and survived for days under water. The ability to generate stable gas bubbles "on demand" using light permits the demonstration of photoinduced flotation and patterned bubble arrays.

A comprehensive update of micro- and nanobubbles as theranostics in oncology

Advances in diagnostic and imaging capabilities have allowed cancers to be detected earlier and characterized more robustly. These strategies have recently branched into theranostics whereby contrast agents traditionally used for imaging have been co-loaded with therapeutics to simultaneously diagnose and treat cancers in a patient-specific manner. Microbubbles (MB) and nanobubbles (NB) are contrast agents which can be modulated to meet the theranostic needs particularly in the realm of oncology. The current review focuses on the ultrasound-responsive MB/NB platforms used as a theranostic tool in oncology. We discuss in detail the key parameters that influence the utility of MB/NB formulations and implications of such treatment modalities. Recent advances in composition strategies, latest works in the pre-clinical stages and multiple paradigm-shifting innovations in the field of MB/NB are discussed in-depth in this review. The clinical application of MB/NB is currently limited to diagnostic imaging. Surface chemistry modification strategies will help tune the formulations toward therapeutic applications. It is also anticipated that MB/NB will see increased use to deliver gas therapeutics. Scalability and stability considerations will be at the forefront as these particles get introduced into the clinical theranostic toolbox.

Optically Driven Gold Nanoparticles Seed Surface Bubble Nucleation in Plasmonic Suspension

Photothermal surface bubbles play important roles in applications like microfluidics and biosensing, but their formation on transparent substrates immersed in a plasmonic nanoparticle (NP) suspension has an unknown origin. Here, we reveal NPs deposited on the transparent substrate by optical forces are responsible for the nucleation of such photothermal surface bubbles. We show the surface bubble formation is always preceded by the optically driven NPs moving toward and deposited to the surface. Interestingly, such optically driven motion can happen both along and against the photon stream. The laser power density thresholds to form a surface bubble drastically differ depending on if the surface is forward- or backward-facing the light propagation direction. We attributed this to different optical power densities needed to enable optical pulling and pushing of NPs in the suspension, as optical pulling requires higher light intensity to excite supercavitation around NPs to enable proper optical configuration.